A U.S. organization can order an Etomidate active pharmaceutical ingredient sample from India for analytical, formulation or non-human research evaluation, provided the material, intended use and import entry are described accurately.
The difficult part is rarely the purchase request itself. Delays usually begin when the requested quantity has no test-based rationale, the COA does not match the offered lot, the SDS is incomplete, or the importer and regulatory information reaches the courier after dispatch.
The practical solution is to complete quality review and import-readiness checks before the supplier books the shipment. This guide explains the information to submit, how to set a defensible sample quantity, which documents to review and what happens after DHL collects the parcel.
Use Restriction: This article concerns legitimate business-to-business evaluation. It does not cover personal use, resale, compounding or human administration of an API sample.
Quick Answer
Send the supplier a written request that identifies Etomidate API, CAS 33125-97-2, the required compendial or in-house specification, the planned tests, the justified quantity and the U.S. receiving party. Review a representative COA and current SDS first. Before shipment, approve the batch-specific COA, confirm the importer of record and customs broker, agree on the Incoterm and freight account, and make sure the invoice, label, packing list and FDA entry data describe the same material and use.
Step-by-Step Guide on How to Order an Etomidate API Sample
Follow this step-by-step guide to learn how to order an Etomidate API sample efficiently:
1. Information to Confirm Before Requesting a Sample
The request should identify the exact material the laboratory intends to evaluate. Etomidate base and a salt form are not interchangeable procurement descriptions. The following information that the buyers need to confirm on their end:
- Product name and CAS number: Etomidate API, 33125-97-2
- Required form, grade and standard, such as USP, BP, Ph. Eur. or an approved internal specification
- Minimum assay, impurity limits and any physical-property requirements
- Planned analytical, preformulation or process-development work
- Requested quantity, delivery address and required receipt date
If method transfer is part of the work, include the analytical methods and reference-standard requirements in the request. This prevents a sample from arriving before the laboratory has the material, columns or standards needed to test it.
2. How Much Etomidate API Should the Buyer Request?
The order quantity depends on your needs and requirements. For laboratory or non-human R&D, FDA Import Alert 66-66 states that entry reviewers may request the specific research use and confirmation that the quantity is reasonable for that work. A request for the largest available sample gives the broker little evidence to support that point.
Here is how much quantity you should order as a sample:
| Indicative Quantity | Typical Evaluation Scope |
| 5 to 10 g | Identity, assay and a limited impurity screen |
| 10 to 25 g | Broader incoming QC, method verification and a retain sample |
| 25 to 50 g | Extended preformulation, solubility or early stability work |
| More than 50 g | Formulation or process work supported by a written consumption estimate |
3. Review the COA Before Approving the Order
A representative certificate of analysis is an earlier batch record used for initial technical screening. It shows the supplier’s test panel and reporting format. The batch-specific COA is the release document for the lot allocated to the shipment and should be approved before dispatch.
For the offered lot, check the product name, CAS number, grade, batch number, manufacturer and retest or expiry dates, appearance, identification, assay, related substances, named impurities, water or loss on drying, residue on ignition or sulfated ash, residual solvents and specific optical rotation where these tests apply. Specifications, actual numerical results, test methods, release date and quality-unit authorization should be visible.
The COA content described in FDA’s ICH Q7 guidance includes the API name and grade, batch number, release date, tests, acceptance limits, numerical results and an authorized quality-unit signature. The buyer still needs supplier qualification and incoming identity testing under its own quality system.
4. Request and Review the SDS
The SDS covers hazards, exposure controls, handling, storage, spill response and transport classification. It is not evidence that the batch meets an API specification. Confirm that the SDS identifies Etomidate and CAS 33125-97-2, names the responsible manufacturer or supplier, gives a revision date and contains the expected 16 section headings.
Under OSHA’s Hazard Communication Standard, Section 14 contains transport information and Section 16 contains preparation or revision information. DHL uses the SDS to assess whether dangerous-goods controls apply. A small net weight does not remove the shipper’s classification duty.
5. Documents to Obtain Before Shipment
The pre-dispatch file should contain the batch-specific COA, current SDS, commercial or pro forma invoice, packing list, label copy, country-of-origin statement, intended-use statement and the air waybill once issued. Depending on the transaction, the buyer may also request a GMP certificate, manufacturer registration and drug-listing information, or a regulatory document reference.
The commercial description must be specific and true. One workable format is: “Etomidate active pharmaceutical ingredient, CAS 33125-97-2, powder, [grade and assay], for [specific evaluation], not for resale or human use,” but only when every part of that statement is accurate. “Chemical sample” and “medicine” are too vague.
A no-charge sample still requires a supportable customs value. U.S. Customs and Border Protection states that CBP will assess a value if none is provided. The invoice and waybill values should agree.
Pro Tip: For more details, you can read our comprehensive guide on documents to request from an Etomidate API supplier,
6. What the U.S. Buyer Must Provide
The supplier and courier need an accountable U.S. party before pickup. The buyer should provide:
- Legal company name, complete delivery and billing addresses, and a named contact with telephone and email
- Specific intended use, evaluation site, requested quantity and the quantity rationale
- Required grade, specification, analytical package and any receiving-temperature limits
- Importer of record and customs broker or entry filer details
- EIN or other import identifier requested by the broker, plus applicable FDA identifiers
- DHL account details if freight is collect, the agreed Incoterm, and responsibility for freight, duty and brokerage
- Receiving hours and confirmation that the site can receive, store and control the material
Do not provide an NDA, ANDA or IND number unless the API, manufacturer, importer or consignee and proposed use are genuinely covered by that application and the party is authorized to refer to it.
7. U.S. FDA and Customs Readiness
According to FDA’s API import guidance, imported APIs generally must address applicable establishment registration, drug listing and labeling requirements. The data required for a particular entry depends on the declared use and regulatory route.
For laboratory or non-human R&D, the intended-use statement should name the tests or development work, identify the site, state that no human administration or resale is planned, explain why the amount is reasonable and describe control or disposal of unused material. Before dispatch, the broker should review the FDA product code, Intended Use Code and applicable Affirmations of Compliance. Manufacturer, product, strength or percent identification, consignee and application data must agree across the entry.
Pro Tip: Not sure about the regulatory documents? Read this guide on the regulatory documents required by the authorities before shipping Etomidate API.
8. Packaging and Shipping from India
The Indian shipper should place the material in a compatible, sealed primary container with a tamper-evident closure and suitable secondary containment. Protection from light, moisture and temperature excursion should follow the material’s stability data. Refrigerated transport should be selected only when the approved storage and shipping basis calls for it.
The primary label should state the product, batch, net quantity, storage conditions and use restriction. Those details must match the COA, packing list, invoice and waybill. Before pickup, the shipper should confirm the tariff classification with the broker, complete the applicable Indian export filing and obtain DHL acceptance for the commodity and packaging configuration.
9. Receipt and Evaluation in the United States
At receipt, inspect the outer package, secondary containment and tamper-evident seal. Reconcile the product name, lot and net quantity against the label, COA and packing list. Record the receipt date and condition, then quarantine the sample under the stated storage conditions until quality review is complete. Perform identity testing and the approved evaluation plan. Document the disposition and retain or dispose of unused material under the site’s procedures.
Post-Sample Receiving Step
Once you have received the sample, review it as per your pharma’s and country’s established parameters. If unsure, read this guide on how to evaluate an Etomidate API sample before placing a commercial order.
Request an Etomidate API Sample With Complete Pre-Dispatch Documentation
Qualified organizations requesting an Etomidate API sample from Velcare Pharma should submit their request now. You can ask for a free custom quote. The sample will be delivered via DHL in 3-5 days all around the globe.
